Sabby Management as of March 31, 2018
Portfolio Holdings for Sabby Management
Sabby Management holds 155 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr option | 29.3 | $260k | 9.9k | 26.32 | |
| Astrazeneca Plc option | 5.8 | $51k | 15k | 3.50 | |
| Biogen Idec (BIIB) | 5.7 | $50k | 183k | 0.27 | |
| Biogen Idec Inc option | 5.5 | $49k | 2.1k | 23.63 | |
| Mannkind (MNKD) | 5.2 | $46k | 203k | 0.23 | |
| Esperion Therapeutics Inc Ne | 4.9 | $44k | 6.1k | 7.23 | |
| Ishares Tr Index option | 4.9 | $44k | 2.9k | 15.18 | |
| Ishares Tr option | 4.3 | $38k | 2.5k | 15.18 | |
| ASTRAZENECA Plc-spons | 3.3 | $29k | 8.4k | 3.50 | |
| Sarepta Therapeutics Inc. cmn | 1.9 | $17k | 2.3k | 7.41 | |
| Zogenix Inc call | 1.8 | $16k | 4.1k | 4.00 | |
| Odonate Therapeutics Ord | 1.8 | $16k | 734k | 0.02 | |
| Merck & Co Inc New option | 1.5 | $14k | 2.5k | 5.45 | |
| Spdr S&p 500 Etf (SPY) | 1.3 | $12k | 45k | 0.26 | |
| Incyte Corp Cmn Stk cmn | 1.2 | $11k | 1.3k | 8.33 | |
| Spdr S&p Oil & Gas Exp & Pr put | 1.1 | $9.8k | 1.1k | 8.77 | |
| Incyte Corp option | 1.1 | $9.5k | 1.1k | 8.33 | |
| Unum Therapeutics Ord | 1.1 | $9.4k | 844k | 0.01 | |
| Nektar Therapeutics | 0.9 | $7.7k | 725.00 | 10.63 | |
| Incyte Corporation (INCY) | 0.8 | $6.8k | 82k | 0.08 | |
| Spark Therapeutics Inc put | 0.8 | $6.8k | 1.0k | 6.66 | |
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 0.8 | $6.6k | 593.00 | 11.15 | |
| Sarepta Therapeutics Inc. cmn | 0.7 | $6.6k | 888.00 | 7.41 | |
| Sangamo Biosciences Inc Cmn Stk cmn | 0.7 | $6.4k | 3.4k | 1.90 | |
| Nektar Therapeutics (NKTR) | 0.7 | $6.2k | 59k | 0.11 | |
| Spark Therapeutics Inc call | 0.6 | $5.2k | 775.00 | 6.66 | |
| Alkermes Plc cmn | 0.4 | $3.9k | 676.00 | 5.80 | |
| Esperion Therapeutics Inc Ne | 0.4 | $3.9k | 538.00 | 7.23 | |
| Global Blood Therapeutics In call | 0.4 | $3.7k | 758.00 | 4.83 | |
| Arcadia Biosciences | 0.4 | $3.6k | 150k | 0.02 | |
| Abbvie | 0.4 | $3.5k | 369.00 | 9.47 | |
| ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.3 | $3.0k | 250.00 | 11.91 | |
| Nektar Therapeutics Cmn Stk cmn | 0.3 | $3.0k | 280.00 | 10.62 | |
| Zogenix Inc put | 0.3 | $2.8k | 687.00 | 4.00 | |
| Sangamo Biosciences (SGMO) | 0.3 | $2.7k | 142k | 0.02 | |
| Amarin Corp Plc option | 0.3 | $2.5k | 8.3k | 0.30 | |
| Aveo Pharmaceuticals | 0.3 | $2.5k | 8.6k | 0.29 | |
| Acceleron Pharma | 0.2 | $2.0k | 524.00 | 3.91 | |
| Citius Pharmaceuticals (CTXR) | 0.2 | $2.0k | 641k | 0.00 | |
| Achaogen Inc put | 0.2 | $1.8k | 1.4k | 1.29 | |
| Oncobiologics | 0.2 | $1.9k | 2.1M | 0.00 | |
| Amyris Inc put | 0.2 | $1.9k | 2.8k | 0.67 | |
| Bristol Myers Squibb Co put | 0.2 | $1.8k | 281.00 | 6.32 | |
| Can-fite Biopharma | 0.2 | $1.7k | 1.2M | 0.00 | |
| Soleno Therapeutics | 0.2 | $1.7k | 918k | 0.00 | |
| Novan | 0.2 | $1.6k | 545k | 0.00 | |
| Cellect Biotechnology Ltd spon ads | 0.2 | $1.6k | 244k | 0.01 | |
| Bristol Myers Squibb (BMY) | 0.2 | $1.5k | 23k | 0.06 | |
| Amicus Therapeutics Inc option | 0.2 | $1.5k | 1.0k | 1.50 | |
| Amicus Therapeutics | 0.2 | $1.5k | 1.0k | 1.50 | |
| Pavmed | 0.2 | $1.5k | 909k | 0.00 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $1.4k | 12k | 0.12 | |
| Esperion Therapeutics (ESPR) | 0.1 | $1.4k | 19k | 0.07 | |
| Prothena Corp | 0.1 | $1.3k | 431.00 | 3.10 | |
| Eleven Biotherapeutics | 0.1 | $1.2k | 1.2M | 0.00 | |
| Insmed | 0.1 | $1.2k | 543.00 | 2.25 | |
| Ovascience | 0.1 | $1.2k | 1.5M | 0.00 | |
| Versartis | 0.1 | $1.1k | 702k | 0.00 | |
| Adverum Biotechnologies | 0.1 | $1.2k | 199k | 0.01 | |
| Zosano Pharma Corp | 0.1 | $1.2k | 234k | 0.01 | |
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 0.1 | $1.1k | 96.00 | 11.15 | |
| Sellas Life Sciences Group I | 0.1 | $1.1k | 309k | 0.00 | |
| Amicus Therapeutics (FOLD) | 0.1 | $973.650000 | 65k | 0.01 | |
| Akebia Therapeutics (AKBA) | 0.1 | $972.211000 | 102k | 0.01 | |
| Neurometrix | 0.1 | $994.544600 | 710k | 0.00 | |
| Adomani | 0.1 | $1.0k | 843k | 0.00 | |
| Vertex Pharmaceuticals Inc option | 0.1 | $861.062000 | 1.3k | 0.65 | |
| Alkermes Plc cmn | 0.1 | $910.003400 | 157.00 | 5.80 | |
| Prothena (PRTA) | 0.1 | $899.150000 | 25k | 0.04 | |
| Synergy Pharmaceuticals Del | 0.1 | $907.077400 | 5.0k | 0.18 | |
| Opgen | 0.1 | $885.829200 | 521k | 0.00 | |
| Achaogen Inc call | 0.1 | $922.978500 | 713.00 | 1.29 | |
| Ampliphi Biosciences | 0.1 | $915.157100 | 832k | 0.00 | |
| Eyenovia Inc equity (EYEN) | 0.1 | $909.261000 | 98k | 0.01 | |
| Biogen Idec Inc option | 0.1 | $821.001000 | 30.00 | 27.37 | |
| Glycomimetics (GLYC) | 0.1 | $835.968600 | 52k | 0.02 | |
| Affimed Therapeutics B V | 0.1 | $765.833400 | 426k | 0.00 | |
| Microbot Med | 0.1 | $874.580000 | 1.2M | 0.00 | |
| Interpace Diagnostics | 0.1 | $827.868600 | 920k | 0.00 | |
| Celsion Corporation | 0.1 | $813.692000 | 370k | 0.00 | |
| Galectin Therapeutics (GALT) | 0.1 | $673.980000 | 143k | 0.00 | |
| Helios & Matheson Informatio | 0.1 | $698.023200 | 249k | 0.00 | |
| Actinium Pharmaceuticals | 0.1 | $799.080000 | 2.0M | 0.00 | |
| Superconductor Technologies | 0.1 | $662.292000 | 736k | 0.00 | |
| Apricus Biosciences | 0.1 | $720.000000 | 1.8M | 0.00 | |
| Mannkind Corp call | 0.1 | $735.072000 | 3.2k | 0.23 | |
| Merck & Co Inc New put | 0.1 | $654.000000 | 120.00 | 5.45 | |
| Applied Dna Sciences | 0.1 | $636.133400 | 454k | 0.00 | |
| Dbv Technologies S A call | 0.1 | $594.999600 | 258.00 | 2.31 | |
| Helios & Matheson Analytics put | 0.1 | $581.076600 | 2.1k | 0.28 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $533.696000 | 172k | 0.00 | |
| Pulmatrix | 0.1 | $543.753500 | 1.1M | 0.00 | |
| Fibrogen | 0.1 | $522.003500 | 113.00 | 4.62 | |
| Fuelcell Energy Inc put | 0.1 | $570.051300 | 3.3k | 0.17 | |
| Adverum Biotechnologies Inc call | 0.1 | $547.992000 | 944.00 | 0.58 | |
| Chf Solutions | 0.1 | $505.394400 | 181k | 0.00 | |
| Auris Medical Newco Holding Ag Namen-akt Isin Ch0408330303 | 0.1 | $548.782400 | 343k | 0.00 | |
| Sangamo Biosciences Inc Cmn Stk cmn | 0.1 | $435.008400 | 229.00 | 1.90 | |
| Transenterix | 0.1 | $436.415500 | 257k | 0.00 | |
| Senestech | 0.1 | $397.370000 | 795k | 0.00 | |
| Precipio | 0.1 | $382.205500 | 764k | 0.00 | |
| Nanovibronix | 0.1 | $411.796800 | 86k | 0.00 | |
| Merck & Co (MRK) | 0.0 | $374.088000 | 6.9k | 0.05 | |
| Amarin Corp Plc option | 0.0 | $334.030800 | 1.1k | 0.30 | |
| Bioamber | 0.0 | $0 | 7.8M | 0.00 | |
| Acceleron Pharma | 0.0 | $338.058600 | 8.6k | 0.04 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $328.300000 | 67k | 0.00 | |
| Eiger Biopharmaceuticals | 0.0 | $315.462000 | 32k | 0.01 | |
| Onconova Therapeutics | 0.0 | $319.664000 | 400k | 0.00 | |
| Sunesis Pharmaceuticals Inc call | 0.0 | $379.991200 | 1.4k | 0.27 | |
| Rosetta Genomics (ROSGQ) | 0.0 | $373.843200 | 935k | 0.00 | |
| Strata Skin Sciences | 0.0 | $378.894000 | 316k | 0.00 | |
| Inpixon | 0.0 | $403.617500 | 367k | 0.00 | |
| Insmed (INSM) | 0.0 | $300.580000 | 13k | 0.02 | |
| Edap Tms S A | 0.0 | $233.956800 | 1.0k | 0.23 | |
| Inspiremd | 0.0 | $243.794000 | 244k | 0.00 | |
| Sonoma Pharmaceuticals | 0.0 | $256.040000 | 69k | 0.00 | |
| Edap Tms (EDAP) | 0.0 | $139.380000 | 61k | 0.00 | |
| Immunogen Inc Cmn Stk cmn | 0.0 | $173.003600 | 164.00 | 1.05 | |
| Bio-path Holdings | 0.0 | $170.026000 | 85k | 0.00 | |
| Acceleron Pharma | 0.0 | $215.000500 | 55.00 | 3.91 | |
| Applied Dna Sciences Inc *w exp 11/21/201 | 0.0 | $129.764800 | 649k | 0.00 | |
| Abeona Therapeutics | 0.0 | $187.171200 | 13k | 0.01 | |
| Fuelcell Energy | 0.0 | $155.380000 | 91k | 0.00 | |
| Axsome Therapeutics (AXSM) | 0.0 | $194.781600 | 81k | 0.00 | |
| Vistagen Therapeutics | 0.0 | $129.137400 | 144k | 0.00 | |
| Sophiris Bio Inc put | 0.0 | $146.966400 | 729.00 | 0.20 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $196.205700 | 654k | 0.00 | |
| Sigma Labs Inc *w exp 02/15/202 | 0.0 | $150.287200 | 376k | 0.00 | |
| Marinus Pharmaceuticals Inc call | 0.0 | $172.011400 | 451.00 | 0.38 | |
| Solid Biosciences | 0.0 | $187.500000 | 25k | 0.01 | |
| Amarin Corporation (AMRN) | 0.0 | $60.900000 | 20k | 0.00 | |
| Prothena Corp | 0.0 | $73.992000 | 240.00 | 0.31 | |
| Galectin Therapeuctics Inc cmn | 0.0 | $100.002000 | 210.00 | 0.48 | |
| Brainstorm Cell Therapeutics (BCLI) | 0.0 | $69.201300 | 22k | 0.00 | |
| Ptc Therapeutics | 0.0 | $84.075000 | 1.5k | 0.06 | |
| Transenterix Inc put | 0.0 | $123.978400 | 728.00 | 0.17 | |
| Vical | 0.0 | $83.764800 | 60k | 0.00 | |
| Sophiris Bio Inc call | 0.0 | $58.000000 | 290.00 | 0.20 | |
| Rxi Pharmaceuticals Corp *w | 0.0 | $78.608800 | 197k | 0.00 | |
| Halozyme Therapeutics (HALO) | 0.0 | $1.999200 | 102.00 | 0.02 | |
| Pluristem Therapeutics | 0.0 | $38.696000 | 28k | 0.00 | |
| Pluristem Therapeutics Inc. cmn | 0.0 | $16.994600 | 122.00 | 0.14 | |
| Volitionrx (VNRX) | 0.0 | $31.600800 | 13k | 0.00 | |
| Check Cap | 0.0 | $37.640000 | 75k | 0.00 | |
| Benitec Biopharma Ltd *w exp 08/14/202 | 0.0 | $17.538600 | 88k | 0.00 | |
| Cytori Therapeuti 18 Wts equities | 0.0 | $0 | 521k | 0.00 | |
| Biocept | 0.0 | $27.712200 | 92k | 0.00 | |
| Versartis Inc call | 0.0 | $3.000000 | 200.00 | 0.01 | |
| Immunocellular Therapeutics *w | 0.0 | $0 | 225k | 0.00 | |
| Inspiremd Inc *w | 0.0 | $0 | 911k | 0.00 | |
| Aquabounty Technologies | 0.0 | $0 | 113.00 | 0.00 | |
| Medigus Ltd sponsord | 0.0 | $30.687800 | 24k | 0.00 | |
| Inspiremd Inc *w exp 03/14/202 | 0.0 | $0 | 2.0M | 0.00 | |
| Sellas Life Sciences Group I | 0.0 | $3.946800 | 1.5k | 0.00 |
